Diabetes Insights - Breakthroughs and Innovators
EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at an EASD Annual Meeting. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/). New episode released every Friday.
The EASD's First Clinical Guideline: Assessment and Management of Diabetes Distress
Now published in Diabetologia
The EASD's first clinical practice guideline has now been published, focusing on the assessment and management of diabetes distress in adults living with type 1 or type 2 diabetes.
Watch the full conversation on YouTube to learn about the very first EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes and type 2 diabetes and how it marks a major shift toward recognising the emotional and psychological burden of living with diabetes. Drawing on two years of multidisciplinary work, the guideline was jointly developed by clinicians, methodologists, psychologists and...
Hot Topics for People Living with Diabetes - Off Label Use, Sensors and Stigma
How can patient voices help shape the future of diabetes care?
Watch the full video on YoutTube. EASD TV host, Vivienne Parry is joined by Bastian Hauck and Renza Scibilia from the Diabetes Online Community (DOC) to discuss some of the most pressing topics facing people living with type 1 diabetes.
The conversation explores the growing interest in emerging therapies - including the off-label use of GLP-1 receptor agonists in type 1 diabetes - the rapid evolution of continuous glucose monitoring technologies, responsible stewardship of health data, and the ongoing global effort to end diabetes stigma.
Central...
When to Exercise and Does it Matter?
Dr Jeroen van der Velde on exercise timing, circadian rhythms and type 2 diabetes
Watch the full video on YouTube. Does exercising in the morning, afternoon or evening make a difference for metabolic health?
In this episode, Dr Jeroen van der Velde discusses the latest evidence on exercise timing and type 2 diabetes, exploring how circadian rhythms influence glucose metabolism and why later-day exercise may offer additional benefits for glycaemic control.
Topics discussed include:
Exercise timing and type 2 diabetes risk Circadian rhythms and metabolic health Morning versus afternoon or evening exercise Chronotypes ("morning larks" and "night...Harvesting the Seeds from Funding Type 1 Diabetes Research
Elizabeth Robertson and Rachel Connor on immunotherapies, screening and the next era of type 1 diabetes research
Watch the full video on YouTube.
In this episode, Elizabeth Robertson (Diabetes UK) and Rachel Connor (Breakthrough T1D) discuss one of the most exciting developments in diabetes research: the growing possibility of delaying and ultimately preventing type 1 diabetes.
Topics discussed include:
The rapid progress of immunotherapies for type 1 diabetes Why early screening is becoming increasingly important The ELSA study and identifying people at risk before clinical diagnosis Stem cell-derived beta cell therapies and the latest clinical trials ...Challenges and Opportunities - How EASD Turned Global
Former Pres. Prof. Stefano Del Prato reflects on navigating COVID-19 and shaping the future of EASD
Watch the full video on YouTube. In this episode, Vivienne Parry speaks with former EASD President Prof. Stefano Del Prato about leading the Association through the COVID-19 pandemic and how one of the most challenging periods in EASD's history became a catalyst for lasting change.
Discover how the rapid transition to a virtual Annual Meeting expanded EASD's global reach, inspired the creation of the Global Council and strengthened international collaboration across the diabetes community.
Prof. Del Prato also reflects...
AI in Diabetes Care
Can AI Really Transform Diabetes Care?
Watch the full video on YouTube. In this episode, Vivienne Parry is joined by Prof. JoĂŁo Filipe Raposo (Portugal) and Prof. Harald Sourij (Austria) for a lively discussion on the opportunities and challenges of artificial intelligence in diabetes care.
Discover how AI is already supporting diabetes management through automated insulin delivery systems, continuous glucose monitoring and personalised risk prediction, while also exploring the evidence still needed before wider implementation in routine clinical practice.
The discussion also covers data privacy, regulation, patient trust and why human expertise and shared d...
Global Collaboration: East - West Exchange to Learn from Each Other
Prof. Daisuke Yabe on East-West Diabetes Research and the Future of Stem Cell Therapy for Diabetes
Watch the full video on YouTube. In this episode of Diabetes Insights, Vivienne Parry speaks with Prof. Daisuke Yabe (Kyoto University) about why EASD has become one of the world's leading forums for diabetes research and collaboration.
The discussion explores how differences in diabetes phenotypes between Europe and East Asia are helping researchers better understand the disease, improve treatments and develop new scientific collaborations across continents.
Professor Yabe also discusses the exciting progress being made in regenerative medicine, including...
What's the Metholodology behind Clinical Guidelines?
Inside the EASD Guideline Development Process
Watch the full video on YouTube. In this episode of Diabetes Insights, Prof. Thomas Karagiannis and Dr Francesco Zaccardi explain the rigorous methodology behind the first EASD clinical guidelines and why robust evidence-based processes are essential for producing trustworthy recommendations.
Discover how guideline development panels are assembled, how conflicts of interest are managed, and why patient perspectives are incorporated alongside scientific evidence. The discussion also explores the first EASD guideline on diabetes distress, future guidance on continuous glucose monitoring in type 2 diabetes, and prevention strategies for people at risk of developing...
Spotlight at Guidelines on Continuous Glucose Monitoring in Type 2 Diabetes
Dame Melanie Davies and Amanda Adler discuss the process, challenge and potential impact of EASDâs new clinical guideline on cgm.
Watch the full video on YouTube. Continuous glucose monitoring (CGM) is becoming an increasingly important part of diabetes care, but how should it be used in people living with type 2 diabetes?
In this episode, Dame Melanie Davies and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on CGM in type 2 diabetes. They explain how guideline topics are selected, the rigorous process of reviewing evidence, and why patient perspectives are essential to developing me...
EASD 2025: Golden Anniversary - 50 years of attending the EASD Annual Meeting
Prof. Standl reflects on his five decade journey with EASD
Watch the the full video on YouTube. In this special episode, Prof. Eberhard Standl celebrates an extraordinary milestone: 50 years since attending his first EASD Congress in 1975.
Prof. Standl reflects on the remarkable progress made in diabetes research and clinical care over the past five decades, from managing diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, and emerging therapies for both type 1 and type 2 diabetes.
The discussion explores the enduring importance of lifestyle interventions, patient-clinician partnerships, diabetes remission, and...
Update of the Consensus Report on the Management of Type 1 Diabetes in Adults
EASD Representives discuss the latest recommendations, diabetes technology and the future of type 1 diabetes care
Watch the full video on YouTube. In this episode, Prof. Richard Holt and Prof. Kirsten NĂžrgaard discuss the updated EASD-ADA Consensus Report on Type 1 Diabetes and explain the key developments shaping modern type 1 diabetes care.
Topics discussed include:
The role of consensus reports within the EASD guidance framework How consensus reports differ from formal clinical guidelines Why the report was updated four years after the original publication Continuous glucose monitoring (CGM) as the current gold standard of care The importance o...Science on Social Media: How to Enter the Arena?
How clinicians can use social media to educate, advocate and improve diabetes care
Watch the full video on YouTube. In this episode of EASD TV, Prof. Partha Kar discusses the opportunities and challenges of social media in healthcare.
The conversation explores how clinicians can use platforms like X, LinkedIn and Substack to share evidence-based information, learn from people living with diabetes and influence policy and implementation in healthcare systems.
Topics discussed include:
Tackling misinformation and harmful health narratives online The role of social media in diabetes advocacy and patient engagement Why clinicians should not...America's Health and Research Landscape at Stake
Diabetes Care Editors discuss the Diabetes Care editorial challenging political threats to science, health equity, and diabetes care.
Watch the full video on YouTube. Dr. Steven Kahn and Dr. John Buse discuss the growing impact of healthcare policy decisions on diabetes care, biomedical research, and public health in the United States and globally.
The conversation explores:
The future of diversity, equity, and inclusion (DEI) in diabetes research Concerns around NIH and CDC funding cuts Political pressures affecting science and healthcare Why chronic disease research must remain a global priority The importance of advocacy from senior leaders...Care for Women with Pre-Existing Diabetes During Pregnancy
Experts discuss preconception care, GLP-1s, CGM use and postpartum support
Watch the full video on YouTube to learn more about the latest international guidelines on diabetes and pregnancy, including recommendations on preconception care, therapeutics, CGM use and postpartum management.
Explore the challenges of managing diabetes before, during, and after pregnancy, including discussions around metformin, GLP-1 receptor agonists, nutrition, breastfeeding and cardiovascular risk.
Learn why experts are calling for more evidence and better coordinated care for women living with diabetes throughout pregnancy and beyond.
Explore the latest EASD Annual Meeting presentations and speaker...
It's All About Us - Taking Lived Experience into Account
Why patient voices are now shaping research, guidelines and global diabetes policy
Watch the full video on YouTube to explore how lived experience is transforming diabetes care, research, and policy.
Discover how the Diabetes Online Community (such as Dedoc°) is influencing clinical guidelines, contributing to research and ensuring that patient voices are embedded across the EASD ecosystem.
Learn more about the growing role of lived experience in healthcare innovation, including patient-led insights into technology, access, and global disparities in diabetes care.
Explore the latest EASD Annual Meeting content and speaker profiles:
Bastian H...Is Type 1 Diabetes a Slow Virus Disease?
From enteroviruses to vaccines: exploring the infection-autoimmunity link
Watch the full video on YouTube to explore the role of viral infections in the development of type 1 diabetes, focusing on the growing evidence linking enteroviruses - particularly Coxsackie B viruses - to disease onset.
Learn how advances in sequencing technologies now allow scientists to detect viruses in human tissues with unprecedented precision, and how long-term cohort studies are helping to identify viral patterns associated with diabetes risk.
The discussion also highlights:
Clinical trials using antiviral therapies to preserve insulin production The development of vaccines targeting...Differences in Diabetes Manifestations across the Globe: Insights from members of the EASD Global Council
Understanding regional challenges, unique phenotypes and the future of global diabetes research
Watch the full video on YouTube to explore how global perspectives are shaping the future of diabetes research and care.
In this episode, experts from the EASD Global Council, Dr. Fawaz Alzaid and Dr. Banshi Saboo, discuss how diabetes presents differently across regions and why these differences matter.
Key topics include:
The role of global collaboration in advancing diabetes science Regional challenges, including climate, diet, and access to care The âthin-fatâ phenotype and its implications for South Asian populations The importance of earl...How Might Anti-Obesity Medication Look Like in the Future?
From GLP-1 therapies to next-generation treatments and long-term weight management
Watch the full video on YouTube to explore the future of anti-obesity medications and emerging therapeutic strategies.
In this episode, experts, Dr. Daniela LiĆkiewicz and Dr. Juan Pablo FrĂas discuss the rapid evolution of obesity pharmacotherapy, from GLP-1 receptor agonists to next-generation combination treatments and oral therapies.
Key topics include:
The shift from injectable to oral and longer-acting medications Multi-agonist therapies targeting multiple metabolic pathways The importance of âquality weight lossâ and preserving muscle mass Challenges in long-term weight maintenance and preventing regain...Diabetologist and Psychologist: How to harness each other's skills?
Integrating mental health into diabetes treatment - from distress to family impact
Watch the full video on YouTube to explore why psychological care is essential in diabetes management and how multidisciplinary teams can improve patient outcomes.
In this episode, experts discuss the growing recognition of mental health in diabetes care, including diabetes distress, depression and fear of hypoglycaemia and how these factors influence both quality of life and clinical outcomes.
Key topics covered:
The psychological burden of living with diabetes Diabetes distress, depression, and fear of hypoglycaemia The role of clinical psychologists within diabetes...The Future of Scientific Publishing: Trust, Transparency and Turbulence
Navigating predatory journals, AI, peer review and the pressure to publish
At the request of EASD's Early Career Academy, this episode confronts the publishing crisis facing scientific research today. A distinguished panel discusses predatory journals, paper mills, AI-generated manuscripts, peer review challenges, and solutions for ensuring research integrity while supporting researchers worldwide.
Featured Guests:
Dr. Pierre Laroumagne: EASD Early Career Academy (former member) Prof. Hindrik Mulder: Editor-in-Chief, Diabetologia Maria Hodges: Publisher, Springer Nature (Diabetologia and Metabologia) Dr. Annette SchĂŒrmann: Representing the peer reviewer perspectiveWatch the full episode on YouTube to hear leading experts e...
Towards arresting type 1 diabetes: Breaking results of the MELD-ATG & Ver-A-T1D trials
Exploring disease-modifying therapies and precision medicine in type 1 diabetes
Watch the full video on YouTube to explore the latest findings from two major clinical trials investigating disease-modifying therapies for type 1 diabetes.
In this episode, Prof. Chantal Mathieu (KU Leuven, endocrinologist and leading researcher in type 1 diabetes) and Prof. Francesco Dotta (University of Siena, expert in type 1 diabetes pathophysiology and clinical trials) discuss the MELD-ATG and VERA-T1D trials conducted through the European INNODIA consortium.
Topics include:
The goals of the INNODIA consortium and its role in advancing type 1 diabetes research The VERA-T1D trial...Clinical Guidelines: How To Develop and Bring Into Practice
How are diabetes guidelines created and how do they change care?
Watch the full video on YouTube to explore how EASD develops clinical guidance and how it shapes diabetes care worldwide.
In this episode, members of the EASD Committee on Clinical Affairs (CCA) discuss:
The role of the Committee in producing consensus reports, expert opinion documents and position statements The launch of EASDâs new guideline programme The first EASD guideline on diabetes distress Upcoming guidelines on continuous glucose monitoring in type 2 diabetes and diabetes prevention The update of the Type 1 diabetes consensus report (EASD/ADA co...Tailored Nutrition and Low-Calorie Diet Remission Updates
How diet, calories and lifestyle changes can reverse diabetes
Watch the full video on YouTube to explore expert insights on nutrition, weight loss, and type 2 diabetes remission.
In this episode, Prof. Nita Forouhi (University of Cambridge) and Prof. Michael Lean (University of Glasgow) discuss:
The impact of ultra-processed foods and red meat on diabetes risk Evidence supporting whole-food, minimally processed diets How significant weight loss can reverse type 2 diabetes and restore organ function The interplay of obesity, fat accumulation in organs, and insulin resistance The importance of patient-centred research and survey-driven priorities Strategies to communicate evidence-based...Recurrent Severe Hypoglycaemic Events: What to do?
Why prevention requires more than algorithms
Watch the full video on YouTube to explore expert perspectives on severe hypoglycaemia in type 1 diabetes and the evolving role of technology, transplantation and psychological support.
In this episode, our expert panel discusses:
Why severe hypoglycaemia remains a major challenge despite automated insulin delivery The limitations of continuous glucose monitoring Impaired awareness and recurrent severe episodes When transplantation may be considered as part of management The psychological trauma and anxiety associated with severe hypoglycaemia How long-standing messaging around glucose targets may increase risk The importance of listening to people with...Dementia in Diabetes - Reasons for Hope or Concern?
How emerging therapies and lifestyle strategies may reshape cognitive outcomes in diabetes
Watch the full video on YouTube to explore the evolving evidence linking diabetes and dementia, and how prevention strategies may reshape long-term outcomes.
In this episode, Prof. Gill Livingston (Unioversity College London) and Prof. Thomas van Sloten (UMC Utrecht) discuss:
The increased risk of dementia in people with diabetes Why type 2 diabetes carries a particularly strong association The impact of cognitive decline on diabetes self-management and quality of life Prevention strategies, including vascular risk management and lifestyle modification Emerging evidence on GLP-1 receptor agonists...EASD Global Council: Making Diabetes Research & Care Equitable Worldwide
Why Global Perspectives Matter in Diabetes Research
Watch the full episode on YouTube to hear Prof. Francesco Giorgino (EASD President) and Prof. Leszek Czupryniak (EASD Global Council Advisor) introduce EASD's newest initiative: the Global Council, launched in Madrid in 2023. This 13-member council brings together diabetes experts from Asia, North and South America, Africa, the Middle East, Australia, and underrepresented regions of Europe to provide direct, active contributions to EASD activities and address global challenges in diabetes research and care. The council's first major achievement is a comprehensive paper published in Diabetologia that identifies global challenges for diabetes research, care...
EASD-ESC Joint Symposium: Hot Topics in Diabetes and Cardiovascular Disease
Heart failure, early risk and the future of integrated diabetes and cardiovascular care
In this episode, a cardiologist (Dr. Kieran Docherty), an epidemiologist (Dr. Paul Welsh) and a diabetologist (Dr. Hertzel C. Gerstein) discuss the growing overlap between diabetes and cardiovascular disease and why collaboration across specialties is essential for patient care. Watch the full episode on YouTube to learn more about how collaboration across disciplines is shaping the future of diabetes and cardiovascular medicine.
Topics discussed include:
Heart failure as a common and under-recognized complication of diabetes Cardiovascular risk in pre-diabetes and early dysglycaemia Why...Diet and Exercise: When, How and What Matters?
How timing of eating and exercise influences metabolism and diabetes risk
Watch the full episode on YouTube to explore how circadian rhythms, meal timing, and exercise interact with metabolism and diabetes risk. Prof. Frédéric Gachon and Prof. Olga Pivovarova-Ramich discuss why _when _we eat matters, how chronotype influences insulin sensitivity and body weight, and what current evidence tells us about intermittent fasting and time-restricted eating.
Topics include:
The role of the central and peripheral body clocks in metabolism Late-night eating, shift work, and metabolic disruption Chronotype and its impact on obesity and insulin sensitivity Me...SURPASS-CVOT: A comparison of Tirzepatide and Dulaglutide
Watch the full episode on YouTube or listen on your preferred podcast platform to explore the SURPASS-CVOT trial results. In this episode, EASD TV Host, Vivienne Parry sits with Prof. Tina VilsbĂžll (EASD Honorary Secretary) and Prof. Hertzel Gerstein (EASD Independent Advisor and McMaster University) as they explain how tirzepatide performs compared to dulaglutide in cardioprotective outcomes. The experts unpack the trialâs implications for clinical practice, highlighting how outcomes trials like this inform personalised medicine, integrate care between diabetologists and cardiologists, and generate new hypotheses in areas such as liver disease, cognitive function, and obesity management
L...
What are the Hot Topics in Diabetes Research from a Journal's Perspective - Diabetologia
In our first episode of 2026, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, offers a journalâs-eye view of the most exciting and challenging developments in diabetes research today. Drawing on his unique overview of submissions from across the global research community, prof. Mulder discusses emerging breakthroughs such as hypoimmune stem cell-based therapies that are transforming from theoretical possibilities into scalable, off-the-shelf treatments for diabetes. Prof. Mulder discusses how these innovations could revolutionise diabetes care by overcoming the historical barriers of islet transplantation. We further explore Diabetologia's special 2025 issue on "Opportunities and Challenges in Diabetes," which tackles the critical issues of healthcare di...
SURPASSing Therapeutic Challenges of Paediatric Type 2 Diabetes with Tirzepatide
In this episode, Dr. Tamara Hannon (Indiana University Health) and Prof. Martin Wabitsch (UniverstÀtsklinikum Ulm) unpack the findings of the SURPASS-PEDS trial - the first study to evaluate the dual GIP/GLP-1 receptor agonist tirzepatide in adolescents with type 2 diabetes. With youth-onset type 2 diabetes rising sharply across the US and Europe, and with young people experiencing faster beta-cell decline, more severe obesity, and greater socioeconomic burdens, the need for effective therapies has never been greater. They discuss why adolescent disease differs fundamentally from adult type 2 diabetes, why weight-loss expectations cannot be compared across age groups, and how tirzepatide not o...
Population Level Screening to Detect Early Stage Type 1 Diabetes
Watch the full video from the EASD 2025 Annual Meeting to learn more about the emerging global consensus on screening for early-stage type 1 diabetes and its implications for clinical practice, public health, and prevention research.
In this episode, Annette Ziegler (Helmholtz Munich), Chantal Mathieu (KU Leuven & EASD President), and Anastasia Albanese-OâNeill (Breakthrough T1D) discuss:
Why early detection matters for preventing diabetic ketoacidosis Recommended screening ages and the three-time childhood screening model The two-step testing approach and its >99% specificity How early diagnosis enables access to disease-modifying therapies Policy considerations for national and regional screening programmes Future di...Results from the SOUL Trial: The Cardiologists' Perspective
Watch the full video on YouTube to explore the cardiologistâs perspective on one of the most important cardiovascular outcomes trials in recent years.
In this episode, Vivienne Parry speaks with Dr Matthew Cavender (University of North Carolina) about the SOUL trial, which evaluated the cardiovascular impact of oral semaglutide in more than 8,000 people with type 2 diabetes.
They discuss:
How oral semaglutide reduced major cardiovascular events by 14% Why an oral GLP-1 receptor agonist may broaden access and adherence Implications for diabetologist's, cardiologists and primary care How team-based care can improve uptake of evidence-based therapies Wh...Results from the SOUL Trial: The Diabetologists' Perspective
Watch the full interview on YouTube to learn more about the SOUL trial, a landmark study presented at the EASD 2025 Annual Meeting investigating cardiovascular outcomes with an oral GLP-1 receptor agonist.
In this episode, Dr Rodica Busui (Oregon Health & Science University-OHSU, Oregon, USA) explains why the SOUL trial represents a significant milestone in diabetes and cardiovascular care. She discusses how the oral formulation achieved a 14% reduction in major adverse cardiovascular events (MACE), matching results previously observed with injectable GLP-1 therapies.
Dr Busui also explores:
The relevance of the findings for people with type 2 diabetes...ATTAIN-1: Investigating Orforglipron for Obesity Management
Watch the full interview on YouTube to learn more about the ATTAIN trial, one of the most anticipated studies at the EASD 2025 Annual Meeting.
In this episode, Dr. Sean Wharton (University of Toronto and Wharton Medical Clinic, Canada) and Dr. Nasreen Alfaris (King Fahad Medical City, Riyadh, Saudi Arabia) discuss how the oral small molecule GLP-1 receptor agonist, Orforglipron, could revolutionise diabetes and obesity care. They explore clinical outcomes, the impact on cardiometabolic health, and why oral therapies may be key to making effective treatments accessible worldwide.
Read the full publication in The New England...
Pancreas Development: A Key to Discover Unexpected Treatments of Diabetes
Watch the full interview on YouTube to hear from Prof. Raphaël Scharfmann (INSERM, Paris), recipient of the 2025 Albert Renold Prize, as he shares insights from decades of pioneering research in pancreatic developmental biology.
In this EASD TV episode, Prof. Scharfmann discusses with Vivienne Parry how fundamental biology is paving the way for future diabetes therapies - from generating functional beta cells from stem cells to understanding how these cells can regulate glucose levels. He also highlights the major collaborative advances that have brought beta cell transplantation closer to reality and the next scientific challenge: finding a w...
EASD-EFSD Rising Stars: The Future of Diabetes Research
Watch the full video on YouTube to meet the EASD Rising Stars of 2025, four early-career scientists redefining diabetes research and clinical care.
In this episode, Vivienne Parry talks with:
Dr Sindre Lee-ĂdegĂ„rd (Norway) - exploring exercise as medicine for high-risk groups, including women with gestational diabetes and South Asians. Dr Martin Schön (Slovakia / Germany) - advancing precision diabetes diagnosis and tailored lifestyle interventions. Dr Cristina Cadenas-SĂĄnchez (Spain) - researching physical activity, childhood obesity, and brain health. Dr Jens Lund (Denmark) - investigating metabolic signaling and the role of lactate in physiology.đ§ Listen...
Impacting Lives of People with Diabetes in Resource Constrained Settings
Watch the full video on YouTube to hear Dr. Viswanathan Mohanâs inspiring journey and how the Global Impact Prize celebrates decades of work transforming diabetes care in India and beyond.
In this episode, Dr Mohan and Vivienne Parry discuss:
The origins of diabetes care as a medical specialty in India The rise of Indiaâs diabetes epidemic and its genetic, dietary, and environmental drivers How large-scale education and prevention programmes are changing outcomes Making technology like CGM more affordable and accessible The future of diabetes research and hope for a type 1 cureListen now for...
Everything you want to know about Adipose Tissue: From Cellular Mechanisms to Clinical Complications
Watch full interview video on YouTube and learn more about the 40th Camillo Golgi prize recipient.
Explore Prof. Rydén's pioneering research into the biology of white adipose tissue, and how it shapes the development and progression of metabolic diseases such as type 2 diabetes and obesity.
Learn about:
How different adipocyte subtypes affect treatment response The discovery that fat cells are continuously renewed in adults The role of inflammation and "stale lipids" in metabolic dysfunction Why adipose tissue composition may drive the success of glucose-lowering therapies and bariatric surgery How single-cell technologies are unlocking n...Back to the future: Re-centring the Role of the Pancreas in Type 2 Diabetes
Watch the full interview on YouTube to explore Dr Teresa Mezzaâs journey as the 2025 EASD Minkowski Prize recipient and how her clinical research is redefining our understanding of type 2 diabetes.
In this episode, Dr Mezza joins Vivienne Parry to discuss:
How studying patients after partial pancreatectomy reveals the natural history of type 2 diabetes The search for simple, predictive biomarkers that identify diabetes risk before symptoms appear The importance of translational research in improving patient outcomes Reflections on the challenges and motivations of being a young diabetes researcher todayDr Mezzaâs work bridges clinical prac...
